| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO And Director | President, CEO And Director | President, CEO &Director +3 more
2 companies
Simmons Jeffrey N is a President, CEO And Director at ELAN, with reported holdings spanning 2 companies. Recent filings cover 8 purchases and 4 sales. Those positions are worth an estimated $168.4M at current prices.
Our model assigns Simmons Jeffrey N a middling insider score of 52/100, based on 5 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +12.3%.
Simmons Jeffrey N's largest disclosed position is in LLY as SVP&Pres. Elanco Animal Health, worth about $164.6M. The recent filings there lean toward selling, a net 51,152 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2017 | LLY Eli Lilly & Co | SVP&Pres. Elanco Animal Health | Sell | 12,500 | $86.46 | $1,080,750.00 | -9.1% | |
| May 29, 2015 | LLY Eli Lilly & Co | SVP&Pres. Elanco Animal Health | Sell | 20,000 | $78.08 | $1,561,600.00 | -17.6% |